Kanneboyina Nagaraju, PhD., DVM

Treasurer, Secretary and Vice President, Research

Dr. Nagaraju is an immunologist and authority in pre-clinical studies in muscular dystrophy animal models, and other inflammatory states. He directed the pre-clinical trials of vamorolone, and has led research to identify and quantify the different subactivities of glucocorticoids and vamorolone. He leads the toxicology and cell biology programs at ReveraGen.